LINC01848: A Drug Target / Disease Biomarker (G100289673)

Target Name: LINC01848

NCBI ID: G100289673

LINC01848

Other Name(s): long intergenic non-protein coding RNA 1848 | Long intergenic non-protein coding RNA 1848

LINC01848: A Drug Target / Disease Biomarker

LINC01848 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders. The gene is located on chromosome 16 and has been shown to play a role in the development and progression of these diseases.

LINC01848 is a non-coding RNA molecule that is composed of approximately 200 amino acid residues. It is expressed in a variety of tissues and cells throughout the body and is involved in the regulation of cellular processes such as cell growth, differentiation, and survival.

One of the most promising aspects of LINC01848 is its potential as a drug target. LINC01848 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and psychiatric disorders.

For example, studies have shown that LINC01848 is highly expressed in cancer tissues and is involved in the regulation of cellular processes that are critical for cancer cell growth and survival. Additionally, LINC01848 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

In addition to its potential as a drug target, LINC01848 has also been shown to be involved in the regulation of cellular processes that are important for overall cellular health and survival. Studies have shown that LINC01848 is involved in the regulation of cell adhesion, a process that is critical for the maintenance of tissue structure and function.

In addition to its potential as a drug target or biomarker, LINC01848 is also of interest as a potential therapeutic agent for the treatment of psychiatric disorders. Studies have shown that LINC01848 is involved in the regulation of cellular processes that are important for the development and progression of psychiatric disorders, such as depression and anxiety.

Overall, LINC01848 is a promising gene that has the potential to be a drug target or biomarker for the treatment of various psychiatric and neurological disorders. Further research is needed to fully understand the role of LINC01848 in these diseases and to develop safe and effective therapies that can be used to treat these conditions.

Protein Name: Long Intergenic Non-protein Coding RNA 1848

The "LINC01848 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01848 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets